Joshua Baisley
About Joshua Baisley
Joshua Baisley serves as the Vice President of Clinical Design and Delivery at SGS Nutrasource, where he has worked since 2013. He is an active member of the probiotic community, has a strong relationship with Health Canada, and has extensive experience in clinical development and quality assurance.
Work at Nutrasource
Joshua Baisley has been with SGS Nutrasource since 2013. He initially served as Associate Director of Clinical Development from 2013 to 2017. In 2017, he transitioned to the role of Director of Clinical Trials, where he has worked for seven years. In 2019, he was promoted to Vice President of Clinical Design and Delivery, a position he has held for five years. His work at Nutrasource focuses on clinical design and delivery within the natural health product sector.
Education and Expertise
Joshua Baisley studied at the University of Guelph from 1996 to 2000, earning a degree that laid the foundation for his career in clinical development. He possesses over 12 years of experience in quality assurance, clinical, preclinical, and regulatory aspects of natural health products. His expertise includes antibody and biologics development, as well as clinical trials management.
Background
Joshua Baisley is an active member of the probiotic community and has contributed to the field through various channels. He has blogged for the International Probiotics Association (IPA) and has presented at probiotic workshops and industry events. His involvement with Health Canada includes participation on an expert working group from 2011 to 2014, where he worked on safety reporting harmonization for supplements, drugs, and biologics.
Achievements
Joshua Baisley has established a respected relationship with Health Canada and is a member of the International Probiotics Association (IPA) Board of Directors. His contributions to the probiotic community and regulatory discussions have been recognized within the industry. He has also worked towards the harmonization of safety reporting standards, reflecting his commitment to improving practices in the natural health product sector.